Subscribe now to our newsletter:

Related blogs

The IPKat

URL: http://ipkitten.blogspot.com

Feed: http://feeds.feedburner.com/theipkat

Type: Network

Last sync: 9 Hours, 1 Minute ago

Google rank (beta): 0 / 10

Technorati authority: 0

Latest posts
Investing for a new trade mark? What do I do with my slogan? NEW
The IPKat 13 Hours, 40 Minutes ago
In yesterday's judgments in Cases T-59/14 ‘INVESTING FOR A NEW WORLD’ and T-609/13 ‘SO WHAT DO I DO WITH MY MONEY’ the General Court of the European Union reviewed the EU case-law on slogan marks, rejecting the appeal of the U...
Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands NEW
The IPKat 20 Hours, 1 Minute ago
This Kat was delighted to receive from Katfriend Rutger M. Kleemans (Freshfields Bruckhaus Deringer LLP, Amsterdam) the following news:Rutger KleemansOn 27 January the Hague Court of Appeal (judges Kalden, Brinkman and Van Nispen) ruled in...
Belgium asks CJEU: does the Enforcement Directive allow cost-capping in IP litigation? NEW
The IPKat 1 Day, 2 Hours, 22 Minutes ago
From Stijn Debaene and Hakim Haouideg (fieldfisher, Brussels: katpat!) comes some pretty hot news from Belgium which ties in to some extent with yesterday's guest Katpost by Barbara Cookson on the recovery of costs in patent litigation -- but it goes...
The patent profession: visions for the future, problems for the present NEW
The IPKat 1 Day, 7 Hours, 41 Minutes ago
The typical successful patent practitionerof the mid-2030s: technically savvy multi-tasking female, working from home ...Visiting a group of patent and trade mark attorneys (but mainly patent folk) the other day for a friendly chat over a sandwich an...
Snatching defeat from the jaws of victory: the pain and the pleasure of a bondage frame dispute NEW
The IPKat 1 Day, 20 Hours, 4 Minutes ago
All litigation takes a toll of litigants, whether in terms of money expended, time consumed, emotions drained or blood pressure sent racing.  The following guest piece, by long-standing Katfriend, IP practitioner, blogger and Old Nick devotee Ba...
Wednesday whimsies NEW
The IPKat 2 Days, 1 Hour, 18 Minutes ago
The Twitter Ten Thousand.  Earlier today the IPKat's Twitter account @ipkat attracted its 10,000th follower.  Although 10,000 is an arbitrary number and carries no greater significance on the IP social media than, say, 9,999 or 10,001, this...
Website blocking in Greece: how does it work there? NEW
The IPKat 2 Days, 6 Hours, 31 Minutes ago
Yannos ParamythiotisDebate around online copyright enforcement has intensified over the past few years, particularly with regard to blocking injunctions, and will likely be even more so this year. The recent decision of the Court of Justice...
Forsgren's SPC: what does the marketing authorisation have to say about the active ingredient? NEW
The IPKat 2 Days, 9 Hours, 11 Minutes ago
In a recent judgment, Case C‑631/13, Arne Forsgren v Österreichisches Patentamt, the Court of Justice of the European Union (CJEU) had to again consider a referral about a Supplementary Protection Certificate (SPC). The judgment was about*...
French say "non!" to nutty name NEW
The IPKat 2 Days, 20 Hours, 45 Minutes ago
"French court stops child from being named Nutella" is the title of a BBC news item today. This item reads, in relevant part: A French court has stopped parents from naming their baby girl Nutella after the hazelnut spread, ruling that it would make...
Life as a patent examiner according to the EPO - paid-for article in the New Scientist NEW
The IPKat 3 Days, 54 Minutes ago
Fresh from publishing the thoughts of a former member of the Boards of Appeal of the European Patent Office, Merpel just noticed this article: A day in the life of a patent examiner appearing in the New Scientist.Merpel was immediately struck by...
Disciplinary authority over the EPO Boards of Appeal: a former member speaks NEW
The IPKat 3 Days, 5 Hours, 6 Minutes ago
A Cat speaks ...The events that unfolded in the European Patent Office (EPO) in Munich in December 2014 have been extensively covered by Merpel on this blog, and have attracted many comments.  Almost the entirety of the internal members, and man...
Linking to infringing content: the story may not be over NEW
The IPKat 3 Days, 5 Hours, 6 Minutes ago
Hyperlinking&copyright fans have already ordered their custom-made T-shirts:what are YOU waiting for?Did you think that the story with copyright and hyperlinks in Europe was over following the decisions of the Court of Justice of the European Uni...
Monday miscellany NEW
The IPKat 4 Days, 4 Hours, 27 Minutes ago
With just six days to go, the IPKat's sidebar poll on IP and the International Women's Leadership Forum has attracted a wide array of opinions and little apparent consensus. Do please feel welcome to participate in this poll (which email subscribers...
Never too late: if you missed the IPKat last week ... NEW
The IPKat 4 Days, 4 Hours, 27 Minutes ago
The IPKat weblog was exceptionally busy last week.  Our page counter recorded no fewer than 39,271 site visits, making it our second best week on record.  Even so, it's possible that, amid the flurry of breaking news and patent revelations,...
Women in IP leadership roles: MIP responds NEW
The IPKat 4 Days, 7 Hours, 17 Minutes ago
Last week, in "A woman's place is in ... the lead: thoughts on an upcoming IP Forum", here, the IPKat reviewed a forthcoming International Women's Leadership Forum on Intellectual Property and asked some fairly simple questions about women's leadersh...
First sale doctrine in the US: a closer look at Costco NEW
The IPKat 4 Days, 21 Hours, 3 Minutes ago
In  last Thursday's round-up, Annsley the AmeriKat brought news of Omega v Costco, a US Court of Appeals for the Ninth Circuit ruling on that most fascinating of legal beasts, first sale doctrine.  Well, the IPKat has just received an analy...
Strategies for patenting biotech inventions: broad claims, changing contributions and data that didn’t make it into the specification NEW
The IPKat 5 Days, 8 Hours, 34 Minutes ago
This is the fourth post in series of six on biotech inventions. The earlier posts can be found here (introductory), here (ethics) and here (case law).The anatomy of a biotech inventionImagine that new human gene, causing activity X in the body, is di...
Pharma and biotech patents: a law unto themselves -- and a litigation conference to match? NEW
The IPKat 1 Week, 2 Hours, 6 Minutes ago
Cloning: a plus for biotechThis Kat, who loves patent law but is no scientist, has been reading, with interest, enjoyment and increasing understanding, the recent blogposts by guest Kat Suleman Ali on the topic of biotech patents. Suleman started the...
Trade mark troubles in the Galápagos islands NEW
The IPKat 1 Week, 2 Hours, 6 Minutes ago
Can there be anywhere on earth whose isolation is more inversely correlated to its contribution to modern scientific thought than the Galápagos archipelago? Located in the Pacific Ocean some 973 km (605 miles) off the west coast of South Ameri...
"New career system" for EPO Examiners: take on extra work NEW
The IPKat 1 Week, 3 Hours, 23 Minutes ago
Examiner by day, novelist by night A product of the free market system, this moggy likes the idea that people can use their spare time for money-generating activities.  It doesn't matter whether they use those extra, unaccounted-for hours d...